Wealthcare Advisory Partners’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-680
Closed -$11.7K 1074
2025
Q4
$11.7K Sell
680
-333
-33% -$6.46K ﹤0.01% 1063
2025
Q3
$26.1K Buy
+1,013
New +$38.3K ﹤0.01% 1013

Other funds holding AGL

Wealthcare Advisory Partners's AGL Position: Q1 2026 in Review

Wealthcare Advisory Partners sold out of Agilon Health (AGL) in Q1 2026, closing a stake of 680 shares — an estimated $11.7K sold.

Wealthcare Advisory Partners first reported a position in AGL in Q3 2025 and held it in 2 quarters. The position peaked at $26.1K in Q3 2025. 97 funds tracked by Wall St. Rank hold AGL as of Q1 2026.

  • Wealthcare Advisory Partners reported no remaining Agilon Health position as of Q1 2026 after selling out during the quarter.
  • Wealthcare Advisory Partners sold 680 Agilon Health shares in Q1 2026, an estimated $11.7K.
  • Wealthcare Advisory Partners first reported a position in Agilon Health in Q3 2025 and held it in 2 quarters.
  • Wealthcare Advisory Partners's Agilon Health position peaked at $26.1K in Q3 2025.
  • 97 funds tracked by Wall St. Rank held Agilon Health as of Q1 2026.

Based on Wealthcare Advisory Partners's 13F filing for Q1 2026, filed 14 Apr 2026.